Triple-negative breast cancer: promising prognostic biomarkers currently in development
Jasmine Sukumar, Kelly C. Gast, Dionisia Quiroga, Maryam B. Lustberg, Nicole Williams
Abstract
: Biomarker-driven care in the management of TNBC is increasing and has helped expand options for patients diagnosed with this subtype of breast cancer. Research efforts are ongoing to identify additional biomarkers and targeted treatment options with the ultimate goal of improving clinical outcomes and survivorship.
Topics & Concepts
MedicineBreast cancerTriple-negative breast cancerBiomarkerEpidermal growth factor receptorCancer researchCancerOncologyMicrosatellite instabilityInternal medicineBiologyGeneBiochemistryAlleleMicrosatelliteCancer Treatment and PharmacologyBreast Cancer Treatment StudiesAdvanced Breast Cancer Therapies